US FDA Wants Advice About Advisory Committees: Try Having Some?

 
• By Michael McCaughan

The FDA’s drug center has all but stopped holding meetings at this point, which begs the question: why do they want advice on how to make them better?

conference room
The focus on adcomm perception does not make much sense given that CDER is having so few meetings, McCaughan argues. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers